biomedcentral.com/content
Bottom,Top,Right1
  • Welcome Bayer Pharma / Bayer Healthcare AG
  • Log on
  • biomed central
  • chemistry central
  • SpringerOpen
BioMed Central
Advanced search
  • Home
  • Journals
  • Articles
  • Gateways
  • About BioMed Central
  • My BioMed Central

Submit a manuscript Register Sign up for article alerts Contact us

Institution search

Search by institution name/city

Members

  • Australia (21)
  • Austria (6)
  • Belgium (3)
  • Brazil (3)
  • Burkina Faso (1)
  • Canada (27)
  • Central African Republic (1)
  • China (3)
  • Cyprus (3)
  • Czech Republic (1)
  • Denmark (1)
  • Ethiopia (1)
  • Finland (6)
  • France (7)
  • Germany (51)
  • Ghana (3)
  • Greece (1)
  • Hong Kong (2)
  • Hungary (1)
  • India (7)
  • Ireland (1)
  • Israel (1)
  • Italy (14)
  • Kenya (3)
  • Korea, South (2)
  • Lebanon (1)
  • Lithuania (1)
  • Luxembourg (1)
  • Madagascar (1)
  • Malaysia (3)
  • Mexico (1)
  • Morocco (2)
  • Netherlands (10)
  • New Zealand (1)
  • Nigeria (2)
  • Norway (4)
  • Poland (2)
  • Portugal (1)
  • Romania (1)
  • South Africa (6)
  • Spain (14)
  • Sweden (9)
  • Switzerland (10)
  • Taiwan (3)
  • Tanzania (2)
  • Thailand (1)
  • Trinidad and Tobago (1)
  • Turkey (1)
  • Uganda (1)
  • United Kingdom (49)
  • United States of America (157)

Advertisement

Member - Bayer Pharma / Bayer Healthcare AG

Bayer Pharma  / Bayer Healthcare AG Payment of your article-processing charges is covered by your organization's Prepay Membership. For article submission you will need the library's subscriber-ID so please contact Monika.Bastian@bayer.com in advance. Read more information about publishing your articles with BioMed Central.

http://www.bayerhealthcare.com


Research staff and students at Bayer Pharma / Bayer Healthcare AG:

Do you realize that you can now publish in journals published by BioMed Central without directly paying any article-processing charges? Payment of your article-processing charges is covered by Bayer Pharma / Bayer Healthcare AG's Prepay Membership. Read more information about publishing your articles with us.



Work published with BioMed Central, Chemistry Central and SpringerOpen by researchers at Bayer Pharma / Bayer Healthcare AG

  • Latest
  • Most viewed RSS
    • Last 30 days
    • Last year

Page 3 of 5

 Previous 1 2 3 4 5  Next

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

51.

Research article   Open Access

Evaluation of long-term antinociceptive properties of stabilized hyaluronic acid preparation (NASHA) in an animal model of repetitive joint pain

Michael Boettger, Diana Kümmel, Andrew Harrison, Hans-Georg Schaible Arthritis Research & Therapy 2011, 13:R110 (7 July 2011)

Abstract | Full text | PDF | PubMed

52.

Research article   Open Access Highly Accessed

Tolerability and efficacy of the intestinal phosphate binder Lantharenol® in cats

Bernard H Schmidt, Ute Dribusch, Peet C Delport, Jürgen M Gropp, F Josef van der Staay BMC Veterinary Research 2012, 8:14 (6 February 2012)

Abstract | Full text | PDF | PubMed

53.

Research   Open Access Highly Accessed

RNA-binding proteins to assess gene expression states of co-cultivated cells in response to tumor cells

Luiz OF Penalva, Michael D Burdick, Simon M Lin, Hedwig Sutterluety, Jack D Keene Molecular Cancer 2004, 3:24 (7 September 2004)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | F1000 Biology

54.

Research article   Open Access

Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor

Raoul Frijters, Wilco Fleuren, Erik JM Toonen, Jan P Tuckermann, Holger M Reichardt, Hans van der Maaden, Andrea van Elsas, Marie-Jose van Lierop, Wim Dokter, Jacob de Vlieg, Wynand Alkema BMC Genomics 2010, 11:359 (5 June 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

55.

Research article   Open Access Highly Accessed

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment

Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, Rene Westhovens, Patrick Durez, Filip Van den Bosch, Eric M Veys, Herman Mielants, Luc De Clerck, Anne Peretz, Michel Malaise, Leon Verbruggen, Nathan Vastesaeger, Anja Geldhof, Luc Boullart, Filip De Keyser Arthritis Research & Therapy 2005, 7:R1063-R1071 (8 July 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

56.

Research   Open Access

Prophylactic treatment with flumethrin, a pyrethroid (Bayticol®, Bayer), against Anaplasma phagocytophilum infection in lambs

Snorre Stuen, Jörg MD Enemark, Karin Artursson, Bent Nielsen Acta Veterinaria Scandinavica 2012, 54:31 (23 May 2012)

Abstract | Full text | PDF | PubMed

57.

Research   Open Access

A flea and tick collar containing 10% imidacloprid and 4.5% flumethrin prevents flea transmission of Bartonella henselae in cats

Michael R Lappin, Wendell L Davis, Jennifer R Hawley, Melissa Brewer, Arianne Morris, Dorothee Stanneck Parasites & Vectors 2013, 6:26 (25 January 2013)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Ctenocephalides felis is a vector for Bartonella henselae and the organism can live in flea frass for at least 9 days. Wearing a collar containing imidacloprid and moxidectin blocked B. henselae infection amongst cats for 8 months. Image: Adult Ctenocephalides felis and frass.

58.

Research article   Open Access

Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG)

Alexander Wall, Thorsten Persigehl, Peter Hauff, Kai Licha, Michael Schirner, Silke Müller, Angelika von Wallbrunn, Lars Matuszewski, Walter Heindel, Christoph Bremer Breast Cancer Research 2008, 10:R23 (10 March 2008)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Perfusion-type cyanine dyes allow for the assessment of angiogenesis in breast cancer tumors using imaging technology, and therefore may help to facilitate the characterization of solid tumors.

59.

Research article   Open Access

Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients

Wulf Siggelkow, Daniel Boehm, Susanne Gebhard, Marco Battista, Isabel Sicking, Antje Lebrecht, Christine Solbach, Birte Hellwig, Jörg Rahnenführer, Heinz Koelbl, Mathias Gehrmann, Rosemarie Marchan, Cristina Cadenas, Jan G Hengstler, Marcus Schmidt BMC Cancer 2012, 12:562 (27 November 2012)

Abstract | Full text | PDF | PubMed

60.

Research   Open Access Highly Accessed

Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion

Satish B Cheepala, Weihong Yin, Zanobia Syed, Jennifer N Gill, Alaina McMillian, Heather E Kleiner, Mark Lynch, Rasiah Loganantharaj, Marjan Trutschl, Urska Cvek, John L Clifford Molecular Cancer 2009, 8:27 (11 May 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

61.

Methodology   Open Access

Correction: RNA interference-mediated gene silencing in murine T cells: in vitro and in vivo validation of proinflammatory target genes

Tatjana C Gust, Luisa Neubrandt, Claudia Merz, Khusru Asadullah, Ulrich Zügel, Arne von Bonin Cell Communication and Signaling 2008, 6:3 (6 August 2008)

Abstract | Full text | PDF | PubMed | 1 comment

62.

Research article   Open Access Highly Accessed

Mining phenotypes for gene function prediction

Philip Groth, Bertram Weiss, Hans-Dieter Pohlenz, Ulf Leser BMC Bioinformatics 2008, 9:136 (3 March 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

63.

Short Report   Open Access

Effect of different UCOE-promoter combinations in creation of engineered cell lines for the production of Factor VIII

Ayyappan R Nair, Xie Jinger, Terry W Hermiston BMC Research Notes 2011, 4:178 (10 June 2011)

Abstract | Full text | PDF | PubMed

64.

Research article   Open Access

Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study

David Price, Anne Robertson, Kevin Bullen, Cynthia Rand, Rob Horne, Heribert Staudinger BMC Pulmonary Medicine 2010, 10:1 (5 January 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

65.

Research article   Open Access Highly Accessed

Cancer Trajectories at the End of Life: is there an effect of age and gender?

Massimo Costantini, Monica Beccaro, Irene J Higginson BMC Cancer 2008, 8:127 (2 May 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Functional deterioration coincides with the terminal phase of life in people with cancer regardless of age or gender, suggesting this decline is an important prognostic factor to be considered for guiding treatment and care advice.

66.

Research article   Open Access

74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis

Isabelle Delabaye, Filip De Keyser, Arthritis Research & Therapy 2010, 12:R121 (22 June 2010)

Abstract | Full text | PDF | PubMed

67.

Original investigation   Open Access

Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study

Wilfried Dinh, Mark Lankisch, Werner Nickl, Daniel Scheyer, Thomas Scheffold, Frank Kramer, Thomas Krahn, Rolf M Klein, Michael Barroso, Reiner Füth Cardiovascular Diabetology 2010, 9:63 (15 October 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

68.

Research   Open Access

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease

Peter MA Calverley, Stephen Rennard, Harold S Nelson, Jill P Karpel, Eduardo H Abbate, Paul Stryszak, Heribert Staudinger Respiratory Research 2008, 9:73 (13 November 2008)

Abstract | Full text | PDF | PubMed

69.

Research   Open Access Highly Accessed

Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitro

Brian N Chorley, Anne L Crews, Yuehua Li, Kenneth B Adler, Michael Minnicozzi, Linda D Martin Respiratory Research 2006, 7:35 (25 February 2006)

Abstract | Full text | PDF | PubMed

70.

Research article   Open Access

Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors

Iannis E Adamopoulos, Cheng-chi Chao, Richard Geissler, Drake Laface, Wendy Blumenschein, Yoichiro Iwakura, Terrill McClanahan, Edward P Bowman Arthritis Research & Therapy 2010, 12:R29 (18 February 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

71.

Research   Open Access

Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer

Klaus Mross, Annette Frost, Max E Scheulen, Jürgen Krauss, Dirk Strumberg, Beate Schultheiss, Ulrike Fasol, Martin Büchert, Jörn Krätzschmer, Heinz Delesen, Prabhu Rajagopalan, Olaf Christensen Vascular Cell 2011, 3:16 (29 July 2011)

Abstract | Full text | PDF | PubMed

72.

Methodology article   Open Access

Combining Shapley value and statistics to the analysis of gene expression data in children exposed to air pollution

Stefano Moretti, Danitsja van Leeuwen, Hans Gmuender, Stefano Bonassi, Joost van Delft, Jos Kleinjans, Fioravante Patrone, Domenico Merlo BMC Bioinformatics 2008, 9:361 (2 September 2008)

Abstract | Full text | PDF | PubMed

73.

Research   Open Access

Comparison between a linear versus a macrocyclic contrast agent for whole body MR angiography in a clinical routine setting

Achim Seeger, Ulrich Kramer, Michael Fenchel, Florian Grimm, Christiane Bretschneider, Jörg Döring, Bernhard Klumpp, Gunnar Tepe, Kilian Rittig, Peter R Seidensticker, Claus D Claussen, Stephan Miller Journal of Cardiovascular Magnetic Resonance 2008, 10:63 (30 December 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

74.

Methodology article   Open Access

High-throughput mammalian two-hybrid screening for protein-protein interactions using transfected cell arrays

Andrea Fiebitz, Lajos Nyarsik, Bernard Haendler, Yu-Hui Hu, Florian Wagner, Sabine Thamm, Hans Lehrach, Michal Janitz, Dominique Vanhecke BMC Genomics 2008, 9:68 (6 February 2008)

Abstract | Full text | PDF | PubMed

75.

Research article   Open Access

Multifaceted effects of synthetic TLR2 ligand and Legionella pneumophilia on Treg-mediated suppression of T cell activation

Wendy WC van Maren, Stefan Nierkens, Liza W Toonen, Judith M Bolscher, Roger PM Sutmuller, Gosse J Adema BMC Immunology 2011, 12:23 (24 March 2011)

Abstract | Full text | PDF | PubMed

Page 3 of 5

 Previous 1 2 3 4 5  Next


  • Terms and Conditions
  • Cookies
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.